Akari Therapeutics Ownership | Who Owns Akari Therapeutics?

Akari Therapeutics Ownership Summary

Akari Therapeutics is owned by 0.26% institutional investors, and 99.74% retail investors. LUX IM Global Medtech HX is the top mutual fund, with 0.11% of its assets in Akari Therapeutics shares.

AKTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Akari Therapeutics	0.26%	-	99.74%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2023	2	100.00%	164,031	-7.89%	-	322.97%	1	-	1	-
Sep 30, 2023	1	-93.75%	178,091	-98.23%	-	0.11%	-	-100.00%	1	-50.00%
Jun 30, 2023	16	45.45%	10,076,550	-0.44%	16	6.14%	6	100.00%	2	-
Mar 31, 2023	11	-26.67%	10,120,691	13.43%	16	7.94%	3	-50.00%	-	-100.00%
Dec 31, 2022	15	15.38%	8,922,318	-11.78%	14	4.92%	6	-	3	200.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
LUX IM Global Medtech HX	13.51K	0.11%	-
Fidelity Nasdaq Composite Index	1.51K	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 18, 2015	Cohen Mark S	-	Buy	$200.04K
Apr 14, 2014	SABBY MANAGEMENT, LLC	-	Buy	$15.63K
Apr 15, 2014	SABBY MANAGEMENT, LLC	-	Buy	$85.50K
Apr 10, 2014	SABBY MANAGEMENT, LLC	-	Buy	$7.35K
Apr 11, 2014	SABBY MANAGEMENT, LLC	-	Buy	$515.00

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

AKTX Ownership FAQ

Who Owns Akari Therapeutics?

Akari Therapeutics shareholders are primarily institutional investors at 0.26%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Akari Therapeutics's industry, Biotech Stocks , is 47.04%, which Akari Therapeutics falls below.

Does Blackrock own Akari Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Akari Therapeutics.

Who is the top mutual fund holder of Akari Therapeutics shares?

LUX IM Global Medtech HX is the top mutual fund holder of Akari Therapeutics shares, with 0.11% of its total shares outstanding invested in 13.51K Akari Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools